ClinicalTrials.gov
ClinicalTrials.gov Menu

Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00284414
Recruitment Status : Withdrawn
First Posted : January 31, 2006
Last Update Posted : May 19, 2009
Sponsor:
Information provided by:
University Hospital, Ghent

Brief Summary:

Patients with Morton neuroma of the foot will undergo either ultrasonography or MRI. The results will be compared.

In case of surgery, the pathology report will be compared with the ultrasonographic or MRI findings.

Which is the most reliable and specific: ultrasonography or MRI?


Condition or disease Intervention/treatment Phase
Morton Neuroma Procedure: Ultrasonography or MRI Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Reliability and specificity of ultrasonography and MRI for detection of Morton neuroma of the foot


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Morton neuroma of the foot

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00284414


Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent

Additional Information:
Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00284414     History of Changes
Other Study ID Numbers: 2004/199
First Posted: January 31, 2006    Key Record Dates
Last Update Posted: May 19, 2009
Last Verified: February 2009

Additional relevant MeSH terms:
Neuroma
Morton Neuroma
Nerve Sheath Neoplasms
Neoplasms, Nerve Tissue
Neoplasms by Histologic Type
Neoplasms
Metatarsalgia
Foot Diseases
Musculoskeletal Diseases
Joint Diseases
Pain
Neurologic Manifestations
Nervous System Diseases
Neuralgia
Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms